Achieve Life Sciences
ACHV
30 hedge funds and large institutions have $11.2M invested in Achieve Life Sciences in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 8 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
1.88% less ownership
Funds ownership: 14.77% → 12.88% (-1.9%)
14% less funds holding
Funds holding: 35 → 30 (-5)
16% less capital invested
Capital invested by funds: $13.4M → $11.2M (-$2.17M)
43% less call options, than puts
Call options by funds: $120K | Put options by funds: $209K
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
+$294K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$213K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$100K |
| 4 |
LPL Financial
San Diego,
California
|
+$61K |
| 5 |
Walleye Capital
New York
|
+$56.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$1.17M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$538K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$263K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$223K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$109K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GGI
26
Godsey & Gibb Inc
Richmond,
Virginia
| $1.87K | – | – | – |
|
|
CPG
27
Cornerstone Planning Group
Fairfield,
New Jersey
| $412 | – | – | – |
|
28
Fidelity Investments
Boston,
Massachusetts
| $338 | +$357 | +82 | New |
|
29
UBS Group
Zurich,
Switzerland
| $8 | -$5.47K | -1,257 | -100% |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| $4 | – | – | – |
|
|
AIC
31
AWM Investment Company
New York
| – | -$1.17M | -272,500 | Closed |
|
|
PCM
32
Perkins Capital Management
Wayzata,
Minnesota
| – | -$538K | -125,212 | Closed |
|
|
PCM
33
Prelude Capital Management
New York
| – | -$109K | -25,429 | Closed |
|
34
Millennium Management
New York
| – | -$102K | -23,605 | Closed |
|
35
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$49.2K | -11,290 | Closed |
|
36
Citadel Advisors
Miami,
Florida
| – | -$29.2K | -6,787 | Closed |
|
37
Morgan Stanley
New York
| – | -$9.46K | -2,200 | Closed |
|
|
CG
38
Cutler Group
San Francisco,
California
| – | -$2K | -479 | Closed |
|
ACHV Hedge Fund Activity: Q4 2023 in Review
30 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2023, worth a combined $11.2M — down 16% from $13.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ACHV and 3 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 11 added.
The largest buyer was J. Goldman & Co, opening a new position worth an estimated $294K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.17M sold.
- 30 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2023, down from 35 in Q3 2023.
- Funds reported $11.2M of Achieve Life Sciences stock for Q4 2023, down 16% quarter-over-quarter.
- 3 funds opened new Achieve Life Sciences positions in Q4 2023 and 8 closed out, a net change of -5 holders.
- The largest Achieve Life Sciences buyer in Q4 2023 was J. Goldman & Co, an estimated $294K added.
- The largest Achieve Life Sciences seller in Q4 2023 was AWM Investment Company, an estimated $1.17M sold.
Based on aggregated 13F filings for Q4 2023.